Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites

References

• Arroyo V, Gines P, Planas R, Panés J, Rodés J. Management of patients with cirrhosis and ascites. Semin Liver Dis 1986;6:353–69.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Sorensen HT. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008;8:3.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
   PubMed Web of Science ®Google Scholar
• Wong F, Girgrah N, Blendis L. Review: the controversy over the pathophysiology of ascites formation in cirrhosis. J Gastroenterol Hepatol 1997;12:437–44.
   Google Scholar
• Ishikawa SE, Schrier RW. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol (Oxf) 2003;58:1–17.
   Web of Science ®Google Scholar
• Madsen M, Pedersen EB, Danielsen H, Jensen LS, Sørensen SS. Impaired renal water excretion in early hepatic cirrhosis. Lack of relationship between renal water excretion and plasma levels of arginine vasopressin, angiotensin II, and aldosterone after water loading. Scand J Gastroenterol 1986;21:749–55.
   PubMed Web of Science ®Google Scholar
• Elliot S, Goldsmith P, Knepper M, Haughey M, Olson B. Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin. J Am Soc Nephrol 1996;7:403–9.
   PubMed Web of Science ®Google Scholar
• Rai T, Sekine K, Kanno K, Hata K, Miura M, Mizushima A, et al. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 1997;8:1357–62.
   PubMed Web of Science ®Google Scholar
• Wen H, Frokiaer J, Kwon TH, et al. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 1999;10:1416–29.
   PubMed Web of Science ®Google Scholar
• Esteva-Font C, Baccaro ME, Fernandez-Llama P, et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome. Hepatology 2006;44:1555–63.
   PubMed Web of Science ®Google Scholar
• Ivarsen P, Frokiaer J, Aagaard NK, Hansen EF, Bendtsen F, Nielsen S, et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut 2003;52:1194–9.
   Google Scholar
• Pedersen RS, Bentzen H, Bech JN, Nyvad O, Pedersen EB. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int 2003;63:1417–25.
   PubMedGoogle Scholar
• Chung SH, Jun DW, Kim KT, Chae JD, Park EK, Son BK, et al. Aquaporin-2 urinary excretion in cirrhosis: relationship to vasopressin and nitric oxide. Dig Dis Sci 2010;55:1135–41.
   Google Scholar
• Gade W, Robinson B. CLS meets the aquaporin family: clinical cases involving aquaporin systems. Clin Lab Sci 2006;19:80–9.
   Google Scholar
• Chen YC, Cadnapaphornchai MA, Schrier RW. Clinical update on renal aquaporins. Biol Cell 2005;97:357–71.
   Google Scholar
• Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995;332:1540–5.
   PubMed Web of Science ®Google Scholar
• Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996;25:135–44.
   PubMed Web of Science ®Google Scholar
• Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006;55:vi1–12.
   PubMed Web of Science ®Google Scholar
• Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, García-Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:986–94.
   PubMed Web of Science ®Google Scholar
• Salerno F, Camma C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007;133:825–34.
   PubMed Web of Science ®Google Scholar
• Pedersen EB, Eiskjaer H, Madsen B, Danielsen H, Egeblad M, Nielsen CB. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant 1993;8:1064–70.
   PubMed Web of Science ®Google Scholar
• Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001;280:F860–7.
   PubMed Web of Science ®Google Scholar
• Krag A, Moller S, Pedersen EB, Henriksen JH, Holstein-Rathlou NH, Bendtsen F. Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system. Liver Int 2010;30:1364–70.
   PubMedGoogle Scholar
• Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002;97:142–8.
   PubMed Web of Science ®Google Scholar
• Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999;29:632–9.
   PubMed Web of Science ®Google Scholar
• Gerbes AL, Gulberg V, Waggershauser T, Holl J, Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998;28:683–8.
   PubMed Web of Science ®Google Scholar
• Wong F, Sniderman K, Liu P, Blendis L. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899–907.
   Google Scholar
• Wong W, Liu P, Blendis L, Wong F. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Am J Med 1999;106:315–22.
   Google Scholar
• Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709–16.
   PubMedGoogle Scholar